Hamamoto, Junko

J-GLOBAL         Last updated: Jun 16, 2019 at 02:40
 
Avatar
Name
Hamamoto, Junko
Affiliation
Keio University
Section
School of Medicine Endowed Course for Lung Cancer Research
Job title
Project Assistant Professor (Non-tenured)/Project Research Associate (Non-tenured)/Project Instructor (Non-tenured)
Degree
医学博士(慶應義塾大学)
Other affiliation
School of Medicine
Research funding number
40570239

Education

 
Mar 2002
   
 
基礎理工学, 理工学, 慶應義塾大学
 

Published Papers

 
Ikemura S., Yasuda H., Matsumoto S., Kamada M., Hamamoto J., Masuzawa K., Kobayashi K., Manabe T., Arai D., Nakachi I., Kawada I., Ishioka K., Nakamura M., Namkoong H., Naoki K., Ono F., Araki M., Kanada R., Ma B., Hayashi Y., Mimaki S., Yoh K., Kobayashi S., Kohno T., Okuno Y., Goto K., Tsuchihara K., Soejima K.
Proceedings of the National Academy of Sciences of the United States of America   116(20) 10025-10030   May 2019
© 2019 National Academy of Sciences. All rights reserved. Next generation sequencing (NGS)-based tumor profiling identified an overwhelming number of uncharacterized somatic mutations, also known as variants of unknown significance (VUS). The the...
Hasegawa H., Yasuda H., Hamamoto J., Masuzawa K., Tani T., Nukaga S., Hirano T., Kobayashi K., Manabe T., Terai H., Ikemura S., Kawada I., Naoki K., Soejima K.
Lung Cancer   127 146-152   Jan 2019
© 2018 Elsevier B.V. Objectives: Epidermal growth factor receptor (EGFR) mutation-positive lung cancer accounts for a significant subgroup of non-small cell lung cancers (NSCLC). Approximately 4–10% of EGFR mutations in NSCLC are EGFR exon 20 inse...
Hamamoto J., Yasuda H., Nonaka Y., Fujiwara M., Nakamura Y., Soejima K., Betsuyaku T.
Biochemical and Biophysical Research Communications   503(3) 1330-1334   Sep 2018
© 2018 Elsevier Inc. Cancers, including lung cancer, are a leading cause of death worldwide. To overcome this deadly disease, multiple modality inhibitors have been developed. These include cytotoxic agents, molecular targeted small molecules, suc...
Hegab A., Ozaki M., Kagawa S., Hamamoto J., Yasuda H., Naoki K., Soejima K., Yin Y., Kinoshita T., Yaguchi T., Kawakami Y., Ornitz D., Betsuyaku T.
Lung Cancer   119 25-35   May 2018
© 2018 Elsevier B.V. Objectives: Tumor-associated macrophages (TAMs) are known to promote tumorigenesis but the mechanism(s) remain elusive. We have developed a mouse model of lung cancer that is initiated through an inducible overexpression of fi...
Hirano T., Yasuda H., Hamamoto J., Nukaga S., Masuzawa K., Kawada I., Naoki K., Niimi T., Mimasu S., Sakagami H., Soejima K., Betsuyaku T.
Molecular Cancer Therapeutics   17(4) 740-750   Apr 2018
© 2018 American Association for Cancer Research. Multiple epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKI) have been developed to effectively inhibit EGFR-derived signals in non–small cell lung cancer (NSCLC). In this ...